0.08
+12.24%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About MariMed
From its filings with the US Securities and Exchange Commission
MariMed is based in Norwood, Massachusetts and is incorporated in Delaware. Its shares trade on OTC under the ticker MRMD. The SEC classifies its business as medicinal chemicals & botanical products. In the fiscal year to 31 December 2025, it reported revenue of $159.8m and a net loss of $14.5m. At that date it held total assets of $202.6m and shareholders' equity of $50.0m. By business, Product sales - retail brought in 55.7% of revenue, followed by Product sales - wholesale at 43.5% and Other revenue at 0.8%.
We are a multi-state cannabis operator (“MSO”) in the United States, headquartered in Norwood, Massachusetts, dedicated to improving lives every day through our high-quality products, our actions, and our values. We develop, own, and manage seed to sale state-licensed, state-of-the-art, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. We have created and continue to develop our own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products utilizing our proprietary strains and formulations. We also license our proprietary brands, in select domestic markets, although licensing revenues are not material to our overall results of operations.
Cannabis remains illegal under United States federal law. Our operations are conducted in compliance with applicable state and local laws and regulations in the jurisdictions in which we operate.
We entered the cannabis industry as an advisory and real estate management firm that procured state-issued cannabis licenses on behalf of our clients, developed cannabis facilities that we leased to these newly licensed companies, and provided industry-leading expertise and oversight in all aspects of their cannabis operations.
Quoted from its 10-K, filed 12 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Industrials
- Industry
- Professional Services
- Listed since
- 4 May 2012
- Employees
- 808
- Website
- marimedadvisors.com ↗
- Head office
- 10 OCEANA WAY, NORWOOD, MA, 02062
- Incorporated in
- DE
- Classification
- Medicinal Chemicals & Botanical Products
- Filer status
- <br>Emerging growth company
Leadership
Pay as last reported
- Mr. Edward GildeaIndependent Non-Executive Chairman of the Board, since 2023$65,750
- Mr. Jon LevinePresident, Chief Executive Officer, Treasurer, Secretary and Director, since 2016$602,554
- Mr. Mario PinhoChief Financial Officer$463,220
- Mr. Timothy ShawChief Operating Officer$177,431
- Mr. Ryan CrandallChief Commercial Officer
- Mr. David AllenIndependent Director$451,862
- Dr. Eva SelhubIndependent Director$60,750
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Marimed Inc has a strong reputation in the medical cannabis industry, known for its high-quality products and services.
- The company has established strategic partnerships with leading cannabis brands, providing it with a competitive edge in the market.
- Marimed Inc benefits from experienced and knowledgeable management, who bring expertise in navigating the evolving regulatory landscape.
Weaknesses
- Marimed Inc currently operates in a highly regulated industry, which can pose challenges and limitations to its growth potential.
- The company's heavy reliance on the legal status of cannabis in various jurisdictions may expose it to legal and regulatory risks.
- Marimed Inc's geographic presence is concentrated in specific regions, limiting its market reach and potential customer base.
Opportunities
- The increasing acceptance of medical cannabis across various states and countries presents a significant growth opportunity for Marimed Inc.
- The company can leverage its partnerships and expertise to expand into new markets and diversify its product offerings.
- With the evolving regulatory landscape, Marimed Inc has the opportunity to shape industry standards and influence policy decisions.
Threats
- The legal and regulatory environment surrounding cannabis remains uncertain, posing potential risks for Marimed Inc's operations.
- Competition within the medical cannabis industry is increasing, with new entrants and established players vying for market share.
- Changes in public opinion or political priorities could impact the demand and acceptance of medical cannabis, affecting Marimed Inc's business.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.